FGF-8 methods of use
US7414019B2 · kind B2 · utility
1Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 3, 2003 |
| Grant date | Aug 19, 2008 |
| Priority date | — |
| Expiry date | Aug 2, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/1825
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention features a method for treating a bone condition in a patient, e.g., a mammal, a human, a horse, a dog, or a cat. The method includes administering an effective amount of FGF-8, FGF-8 analog, or a FGF-8 agonist to the patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.